EUVIMEDEUVIMED entdecken
Crossref

Clinicopathological features and mutational landscape of colorectal cancer subgroups defined by MSI and EMAST status

Tamara Cacev, Kristina Vuković Đerfi, Anamarija Salar, Sonja Marinović, Emilija Zapletal, Vesna Musani, Anita Škrtić, Arijana Pačić, Sanja Kapitanović

Pathology - Research and Practice · 2026

DOI: 10.1016/j.prp.2025.156302 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology - Research and Practice, 2026. Verfasst von Tamara Cacev und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Personalized Medicine, Division of Molecular Medicine, Rudjer Boskovic Institute, Bijenicka cesta 54, Zagreb 10000, Croatia. Electroni…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Microsatellite Instability, Microsatellite Repeats. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Croatian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) remains a leading cause of cancer-related morbidity and mortality. Microsatellite instability-high (MSI-H) tumors, resulting from defective DNA mismatch repair (MMR), represent a well-defined subtype with distinctive biological behavior and immunogenicity. In contrast, tumors with elevated microsatellite alterations at tetranucleotide repeats (EMAST) are less well characterized. EMAST can manifest with MSI or arise as an isolated form of instability, delineating discrete phenotypes underpinned by distinct mechanisms. This study aimed to characterize MSI and EMAST status in CRCs. By integrating instability profiles with clinicopathological features and mutational profiles of key driver genes, we aimed to refine molecular classification and advance understanding of CRC tumorigenesis. A total of 332 CRCs were analyzed for MSI and EMAST using established panels. Clinicopathological characteristics were recorded, and mutational profiling of KRAS, BRAF, CTNNB1, PIK3CA, and TP53 was performed. MLH1 expression was assessed using immunohistochemistry. MSS/EMAST-S tumors displayed profiles typical of chromosomally stable CRC, dominated by KRAS and followed by TP53 and PIK3CA mutations. MSI-H/EMAST-H tumors were characterized by frequent BRAF mutations, right-sided location, female predominance, and lower TP53 mutation rate, consistent with the classical hypermutated, immunogenic subtype. In contrast, MSS/EMAST-H tumors exhibited unique features, including enrichment for PIK3CA and CTNNB1 mutations, larger tumor size, and poorer differentiation, suggesting an intermediate phenotype between MSS and MSI-H. MSS/EMAST-L tumors aligned with chromosomally stable, KRAS/Wnt-driven CRC. In conclusion, MSS/EMAST-H tumors represent an underrecognized CRC subtype with intermediate genomic instability and a distinctive molecular profile, with potential implications for prognostic assessment and personalized therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsMicrosatellite InstabilityMicrosatellite RepeatsHumansFemaleMaleMiddle AgedAgedMutationAdultAged, 80 and overBiomarkers, TumorDNA Mismatch Repair

Stichwörter der Autor:innen

BRAFCTNNB1Colorectal cancerEMASTKRASMLH1MSIPIK3CATP53

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Laboratory for Personalized Medicine, Division of Molecular Medicine, Rudjer Boskovic Institute, Bijenicka cesta 54, Zagreb 10000, Croatia. Electronic address: tcacev@irb.hr.
  • Laboratory for Personalized Medicine, Division of Molecular Medicine, Rudjer Boskovic Institute, Bijenicka cesta 54, Zagreb 10000, Croatia. Electronic address: kvukovic@irb.hr.
  • Laboratory for Personalized Medicine, Division of Molecular Medicine, Rudjer Boskovic Institute, Bijenicka cesta 54, Zagreb 10000, Croatia. Electronic address: salar.anamarija@gmail.com.
  • Laboratory for Personalized Medicine, Division of Molecular Medicine, Rudjer Boskovic Institute, Bijenicka cesta 54, Zagreb 10000, Croatia. Electronic address: smarinov@irb.hr.
  • Laboratory for Personalized Medicine, Division of Molecular Medicine, Rudjer Boskovic Institute, Bijenicka cesta 54, Zagreb 10000, Croatia. Electronic address: emilija.zapletal@irb.hr.
  • Laboratory for Personalized Medicine, Division of Molecular Medicine, Rudjer Boskovic Institute, Bijenicka cesta 54, Zagreb 10000, Croatia. Electronic address: vmusani@irb.hr.

Förderung

  • Croatian Science Foundation

Zitieren

APA

Cacev, T., Đerfi, K. V., Salar, A., Marinović, S., Zapletal, E., Musani, V., Škrtić, A., Pačić, A., & Kapitanović, S. (2026). Clinicopathological features and mutational landscape of colorectal cancer subgroups defined by MSI and EMAST status. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2025.156302

Vancouver

Cacev T, Đerfi KV, Salar A, Marinović S, Zapletal E, Musani V, et al. Clinicopathological features and mutational landscape of colorectal cancer subgroups defined by MSI and EMAST status. Pathology - Research and Practice. 2026. doi:10.1016/j.prp.2025.156302

BibTeX
@article{Cacev2026,
  author = {Cacev, Tamara and Đerfi, Kristina Vuković and Salar, Anamarija and Marinović, Sonja and Zapletal, Emilija and Musani, Vesna and Škrtić, Anita and Pačić, Arijana and Kapitanović, Sanja},
  title = {Clinicopathological features and mutational landscape of colorectal cancer subgroups defined by MSI and EMAST status},
  journal = {Pathology - Research and Practice},
  year = {2026},
  doi = {10.1016/j.prp.2025.156302}
}
Kostenlos starten →